Aztreonam Renal Dosing Recommendations
For patients with renal impairment, aztreonam requires dose reduction based on creatinine clearance, with the standard approach being to halve the dose for moderate impairment (CrCl 10-30 mL/min) and reduce to one-quarter for severe impairment (CrCl <10 mL/min), always after giving a full initial loading dose. 1
Dosing Algorithm by Creatinine Clearance
Normal Renal Function (CrCl >30 mL/min)
- Loading dose: 1-2 g IV (based on infection severity)
- Maintenance:
- Urinary tract infections: 500 mg or 1 g every 8-12 hours
- Moderate systemic infections: 1-2 g every 8-12 hours
- Severe/life-threatening infections: 2 g every 6-8 hours
- No dose adjustment needed 1
Moderate Renal Impairment (CrCl 10-30 mL/min)
- Loading dose: Full dose (1-2 g) initially
- Maintenance: Half the usual dose at the standard interval (every 6,8, or 12 hours)
- Example: If usual dose is 2 g q8h → give 1 g q8h 1
Severe Renal Impairment (CrCl <10 mL/min)
- Loading dose: Full dose (500 mg, 1 g, or 2 g) initially
- Maintenance: One-quarter of the usual initial dose at the standard interval
- Example: If usual dose is 2 g q8h → give 500 mg q8h 1
Hemodialysis Patients
- Loading dose: Full dose (500 mg, 1 g, or 2 g)
- Maintenance: One-quarter of usual dose at standard intervals
- Supplemental dose: Give one-eighth of the initial dose after each hemodialysis session
- Administer doses after dialysis to avoid drug removal 1
Critical Implementation Points
Always give a full loading dose regardless of renal function. The loading dose compensates for the increased volume of distribution in critically ill patients and ensures adequate initial drug exposure 1. The serum half-life increases from 1.7 hours in normal renal function to 6-8 hours in anephric patients, necessitating maintenance dose reduction but not loading dose reduction 2, 3.
Use actual creatinine clearance calculations, not just serum creatinine. When only serum creatinine is available, use the Cockcroft-Gault formula provided in the FDA label:
- Males: CrCl = [weight (kg) × (140 - age)] / [72 × serum creatinine (mg/dL)]
- Females: 0.85 × above value 1
For Pseudomonas aeruginosa infections, use 2 g every 6-8 hours at minimum during initial therapy, even with dose adjustments for renal impairment, as this pathogen requires higher sustained concentrations 1.
Pharmacokinetic Rationale
Aztreonam is 60-70% renally excreted unchanged, with renal clearance averaging 56 mL/min in healthy subjects 1. Total clearance correlates directly with creatinine clearance (r = 0.97) 2. In patients with CrCl <10 mL/min, total clearance drops to approximately 29 mL/min, and urinary recovery decreases from 60-70% to less than 2% of the administered dose 2, 3.
The drug achieves therapeutic concentrations exceeding MIC90 for Enterobacteriaceae for 8 hours after standard dosing in normal renal function, but this is prolonged in renal impairment, allowing for dose reduction without compromising efficacy 1.
Common Pitfalls to Avoid
Do not skip the loading dose in renal impairment. Recent population pharmacokinetic modeling confirms that omitting the loading dose results in inadequate early drug exposure, particularly in patients with CrCl 31-50 mL/min 4. The loading dose should match the full unitary dose used in patients without renal failure.
Do not use serum creatinine alone in elderly patients. Elderly patients may have diminished renal function despite normal serum creatinine due to reduced muscle mass. Always calculate creatinine clearance 1.
Hemodialysis removes approximately 50% of aztreonam during a 4-hour session 3, making post-dialysis supplementation essential. Peritoneal dialysis removes minimal drug and does not require supplementation 5.